2025-524376-36-00已完成4 期
Bioequivalence study comparing two temazepam 20 mg tablet formulations after fasted administration; an open, randomized, single centre, single dose study with crossover design in healthy subjects
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
clinical department
Scientific
Orion Corporation
研究点 (3)
Loading locations...
相似试验
尚未招募
不适用
A randomized, open-label, two-treatment, four-cohort, two-period, two-sequence, crossover, single-dose, oral comparative pharmacokinetic and bioequivalence study under fasting conditions.CTRI/2025/11/097344Birla Institute of Technology48
已完成
4 期
Bioequivalence study 2 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteersParkinson desease2026-525449-57-00Orion Corporation40
已完成
1 期
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy AdultsNCT07261371Pfizer64
尚未招募
不适用
A Study to Compare Biphasic Insulin Aspart Injection (30/70) with NovoMix ® 30 in healthy adult male subjectsCTRI/2026/02/104468Wockhardt limited18
已完成
4 期
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatment and prevention of Influenza.influenza2024-515436-76-00Adamed Pharma S.A.54